Sufentanil Related Products


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Sufentanil, pharmacopeial and non-pharmacopeial Sufentanil impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Sufentanil impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Sufentanil-related products are thoroughly characterized. Sufentanil products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Sufentanil Citrate EP Impurity A

SZ目录编号:: SZ-S080002
CAS 号: 61086-18-8
分子式: C16H24N2O2
分子量: 276.4
投资状态: Custom Synthesis
Rel. CAS No: 84196-16-7 (HCl salt)

Sufentanil Citrate EP Impurity B

SZ目录编号:: SZ-S080003
CAS 号: 2250242-55-6
分子式: C22H30N2O3S
分子量: 402.6
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity C

SZ目录编号:: SZ-S080004
CAS 号: 164790-59-4
分子式: C18H24N2OS
分子量: 316.5
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity D

SZ目录编号:: SZ-S080005
CAS 号: 2250243-42-4
分子式: C21H28N2O2S
分子量: 372.5
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity E

SZ目录编号:: SZ-S080006
CAS 号: 72996-73-7
分子式: C19H26N2OS
分子量: 330.5
投资状态: Custom Synthesis
Rel. CAS No: 72996-74-8 (2HCl salt)

Sufentanil Citrate EP Impurity F

SZ目录编号:: SZ-S080007
CAS 号: 79146-60-4
分子式: C22H30N2O2S
分子量: 386.6
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity G

SZ目录编号:: SZ-S080008
CAS 号: 119997-43-2
分子式: C24H32N2O3S
分子量: 428.6
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity H

SZ目录编号:: SZ-S080009
CAS 号: 2250243-57-1
分子式: C23H32N2O2S
分子量: 400.6
投资状态: Custom Synthesis

Sufentanil Citrate EP Impurity I

SZ目录编号:: SZ-S080010
CAS 号: NA
分子式: C22H30N2O3S
分子量: 402.6
投资状态: Custom Synthesis
categories